← All trials
NCT05172817
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 2, 2021
- Primary completion
- Nov 30, 2021
- Completion date
- Oct 30, 2022
- First posted
- Dec 29, 2021
- Last posted
- Jul 7, 2022
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institute for Developing Science and Health Initiatives, BangladeshLead sponsor
- Incepta Vaccine LimitedCollaborator
- Institute for Developing Science and Health Initiatives, BangladeshReponsible party - principal investigator
- Universal Medical College Hospital, BangladeshCollaborator
- Institute for Developing Science and Health Initiatives, BangladeshSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.